A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination

N Engl J Med. 2022 Jan 27;386(4):394-396. doi: 10.1056/NEJMcibr2113694. Epub 2021 Nov 24.

Authors

William J Murphy¹, Dan L Longo¹

Affiliation

¹ From the Departments of Dermatology and Internal Medicine, Division of Hematology and Oncology, University of California, Davis, Sacramento (W.J.M.).

PMID: 34818473
DOI: 10.1056/NEJMcibr2113694

No abstract available

MeSH terms

Angiotensin-Converting Enzyme 2 / physiology
Animals
Antibodies, Anti-Idiotypic / immunology*
Antibodies, Neutralizing / immunology
Antibodies, Viral / immunology*
COVID-19 / immunology*
COVID-19 Vaccines / immunology*
Disease Models, Animal
Humans
Immunoglobulin Idiotypes / immunology
Mice
Mice, Transgenic
SARS-CoV-2 / immunology*
Spike Glycoprotein, Coronavirus / immunology*
Vaccination

Substances

Antibodies, Anti-Idiotypic
Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
Immunoglobulin Idiotypes
Spike Glycoprotein, Coronavirus
Angiotensin-Converting Enzyme 2